Login to Your Account

BI to Provide Sales Heft to Marinomed's Cold Spray Drug

By Cormac Sheridan

Wednesday, June 30, 2010
Marinomed Biotechnologie GmbH is banking an undisclosed up-front payment of several million Euros on the back of a distribution deal it has entered with Boehringer Ingelheim GmbH involving its antiviral nasal spray for the common cold. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription